本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

6.66
-0.3800-5.40%
盘后6.57-0.0900-1.35%19:50 EDT
成交量:5.62万
成交额:37.82万
市值:4,121.07万
市盈率:-2.72
高:7.06
开:7.05
低:6.56
收:7.04
52周最高:13.69
52周最低:3.76
股本:618.78万
流通股本:300.20万
量比:1.32
换手率:1.87%
股息:- -
股息率:- -
每股收益(TTM):-2.4500
每股收益(LYR):-2.4500
净资产收益率:-196.92%
总资产收益率:-69.33%
市净率:0.77
市盈率(LYR):-2.72

数据加载中...

2024/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/25

重要事件披露

Form 8-K - Current report
2023/11/23

SEC问询函

Form CORRESP - Correspondence
2023/11/23

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/06

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]